Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.24 +0.01 (+0.71%)
As of 04/30/2025

DHAC vs. ENZ, MRAI, BRTX, KDLY, MGRX, OTRK, SSY, BGLC, ACON, and ATIP

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Enzo Biochem (ENZ), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs.

Enzo Biochem (NYSE:ENZ) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Enzo Biochem received 212 more outperform votes than Digital Health Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Enzo BiochemOutperform Votes
212
52.61%
Underperform Votes
191
47.39%
Digital Health AcquisitionN/AN/A

Enzo Biochem has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.

36.9% of Enzo Biochem shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 11.4% of Enzo Biochem shares are held by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Digital Health Acquisition has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. Digital Health Acquisition's return on equity of 0.00% beat Enzo Biochem's return on equity.

Company Net Margins Return on Equity Return on Assets
Enzo Biochem-75.34% -7.96% -5.49%
Digital Health Acquisition N/A N/A N/A

Digital Health Acquisition has lower revenue, but higher earnings than Enzo Biochem.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enzo Biochem$29.09M0.59-$26.08MN/AN/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

In the previous week, Enzo Biochem had 1 more articles in the media than Digital Health Acquisition. MarketBeat recorded 1 mentions for Enzo Biochem and 0 mentions for Digital Health Acquisition. Enzo Biochem's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
Enzo Biochem Neutral
Digital Health Acquisition Neutral

Summary

Enzo Biochem beats Digital Health Acquisition on 6 of the 9 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices Industry SectorNASDAQ Exchange
Market Cap$4.47M$473.79M$2.43B$7.92B
Dividend YieldN/A7.74%13.17%4.22%
P/E RatioN/A2.4110.8518.54
Price / SalesN/A54.243,410,844.20103.35
Price / CashN/A69.0154.9934.62
Price / BookN/A3.663.114.25
Net IncomeN/A$35.22M-$305.73M$248.18M
7 Day Performance4.20%2.63%0.94%1.25%
1 Month Performance10.71%4.42%-0.19%3.76%
1 Year Performance-89.67%24.20%11.81%5.28%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.24
+0.7%
N/A-89.7%$4.47MN/A0.002,021
ENZ
Enzo Biochem
0.5484 of 5 stars
$0.33
-14.8%
N/A-69.0%$17.03M$29.09M0.00520Gap Down
High Trading Volume
MRAI
Marpai
N/A$0.96
flat
N/A-50.7%$14.30M$34.87M-0.36150Upcoming Earnings
BRTX
BioRestorative Therapies
3.9703 of 5 stars
$1.73
flat
$18.00
+940.5%
+23.9%$12.98M$401,000.00-1.137Short Interest ↓
Positive News
KDLY
Kindly MD
1.2737 of 5 stars
$1.78
+7.9%
N/AN/A$10.73M$2.72M-2.70N/AShort Interest ↓
Positive News
Gap Up
MGRX
Mangoceuticals
0.911 of 5 stars
$2.04
-8.9%
N/A-97.0%$10.55M$615,873.00-0.353Short Interest ↓
Gap Up
High Trading Volume
OTRK
Ontrak
3.2348 of 5 stars
$1.54
+7.7%
$45.00
+2,822.1%
-64.7%$6.50M$10.85M-0.15250Short Interest ↓
SSY
SunLink Health Systems
N/A$0.90
flat
N/A+64.6%$6.34M$31.23M6.431,376Gap Up
BGLC
BioNexus Gene Lab
0.2659 of 5 stars
$2.89
+3.6%
N/A-54.0%$5.19M$9.26M0.0030Short Interest ↑
News Coverage
Gap Down
ACON
Aclarion
1.5149 of 5 stars
$7.70
+2.5%
$11,758.50
+152,607.8%
-99.8%$4.48M$45,724.000.007Gap Down
ATIP
ATI Physical Therapy
N/A$1.00
+15.6%
N/A-80.9%$4.41M$741.86M-0.055,600Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners